Uret 17 ((free)) -

Bladder cancer is a significant global health concern, ranking as the fourth most common malignancy in men. For years, the "gold standard" for diagnosis has been , a painful and invasive procedure that involves inserting a camera into the bladder.

: You can find selected papers from this meeting through platforms like ResearchGate or the American Nuclear Society (ANS) archives. 2. URO17™ Bladder Cancer Biomarker uret 17

: The test identifies the presence of the Keratin 17 (K17) oncoprotein in urine samples. While K17 is normal in hair and nails, its re-expression in the lining of the bladder is a strong indicator of malignancy. Bladder cancer is a significant global health concern,

is an immunocytochemistry assay that serves as a highly accurate alternative or adjunct to traditional, more invasive diagnostic methods. Sensitivity & Specificity: Clinical studies have reported an exceptional 100% sensitivity 96% specificity in detecting recurrent urothelial cancers. It is used for both the initial diagnosis is an immunocytochemistry assay that serves as a